Bergmann Anthony 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Oct 24, 2023
Insider Transaction Report
Form 4
Bergmann Anthony
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-10-23$1.39/sh+2,178$3,027→ 2,381 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-10-23−2,178→ 0 totalExercise: $1.39Exp: 2023-10-23→ Common Stock (2,178 underlying)
Footnotes (2)
- [F1]This option was granted on October 23, 2013 and was previously reported as covering 21,785 shares at an exercise price of $0.30 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F2]The shares vested annually over a 4 year period commencing on November 1, 2014.